Association of Induced Hyperhomocysteinemia with Alzheimer’s Disease-Like Neurodegeneration in Rat Cortical Neurons After Global Ischemia-Reperfusion Injury
暂无分享,去创建一个
M. Adamkov | B. Tóthová | Z. Tatarková | A. Tomašcová | J. Lehotský | M. Kovalska | D. Kalenská | L. Kovalska | Z. Tatarkova | Barbara Tóthová
[1] R. Pluta,et al. Ischemic tau protein gene induction as an additional key factor driving development of Alzheimer’s phenotype changes in CA1 area of hippocampus in an ischemic model of Alzheimer’s disease , 2018, Pharmacological reports : PR.
[2] S. Yen,et al. Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization , 2018, International journal of molecular sciences.
[3] R. Shytle,et al. Therapeutic Cocktail Approach for Treatment of Hyperhomocysteinemia in Alzheimer’s Disease , 2018, Cell medicine.
[4] R. Pluta,et al. Autophagy, mitophagy and apoptotic gene changes in the hippocampal CA1 area in a rat ischemic model of Alzheimer’s disease , 2017, Pharmacological reports : PR.
[5] D. Wilcock,et al. Hyperhomocysteinemia-Induced Gene Expression Changes in the Cell Types of the Brain , 2017, ASN neuro.
[6] Guowei Huang,et al. Homocysteine induces mitochondrial dysfunction involving the crosstalk between oxidative stress and mitochondrial pSTAT3 in rat ischemic brain , 2017, Scientific Reports.
[7] L. Bobermin,et al. Homocysteine Induces Glial Reactivity in Adult Rat Astrocyte Cultures , 2017, Molecular Neurobiology.
[8] O. Krizanova,et al. Effect of Hyperhomocysteinemia on Redox Balance and Redox Defence Enzymes in Ischemia–Reperfusion Injury and/or After Ischemic Preconditioning in Rats , 2017, Cellular and Molecular Neurobiology.
[9] S. Merali,et al. Homocysteine modulates 5‐lipoxygenase expression level via DNA methylation , 2016, Aging cell.
[10] D. Dobrota,et al. Role of Homocysteine in the Ischemic Stroke and Development of Ischemic Tolerance , 2016, Front. Neurosci..
[11] M. Jabłoński,et al. Dysregulation of Autophagy, Mitophagy, and Apoptotic Genes in the Medial Temporal Lobe Cortex in an Ischemic Model of Alzheimer’s Disease , 2016, Journal of Alzheimer's disease : JAD.
[12] Guowei Huang,et al. Homocysteine Aggravates Cortical Neural Cell Injury through Neuronal Autophagy Overactivation following Rat Cerebral Ischemia-Reperfusion , 2016, International journal of molecular sciences.
[13] M. Jabłoński,et al. Alzheimer-associated presenilin 2 gene is dysregulated in rat medial temporal lobe cortex after complete brain ischemia due to cardiac arrest , 2016, Pharmacological reports : PR.
[14] M. Adamkov,et al. Combination of hyperhomocysteinemia and ischemic tolerance in experimental model of global ischemia in rats. , 2015, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[15] M. Jabłoński,et al. Dysregulation of Amyloid-β Protein Precursor, β-Secretase, Presenilin 1 and 2 Genes in the Rat Selectively Vulnerable CA1 Subfield of Hippocampus Following Transient Global Brain Ischemia , 2015, Journal of Alzheimer's disease : JAD.
[16] H. Gertz,et al. Early neurone loss in Alzheimer’s disease: cortical or subcortical? , 2015, Acta neuropathologica communications.
[17] S. Tyagi,et al. Hydrogen Sulfide Epigenetically Attenuates Homocysteine‐Induced Mitochondrial Toxicity Mediated Through NMDA Receptor in Mouse Brain Endothelial (bEnd3) Cells , 2015, Journal of cellular physiology.
[18] M. Fiuza,et al. Differential Tiam1/Rac1 Activation in Hippocampal and Cortical Neurons Mediates Differential Spine Shrinkage in Response to Oxygen/Glucose Deprivation , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[19] Dong Young Lee,et al. Association of homocysteine with hippocampal volume independent of cerebral amyloid and vascular burden , 2014, Neurobiology of Aging.
[20] S. Merali,et al. Homocysteine exacerbates β‐amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles , 2014, Annals of neurology.
[21] B. Friguet,et al. Protein damage, repair and proteolysis. , 2014, Molecular aspects of medicine.
[22] Torbjörn Persson,et al. Oxidative Stress in Alzheimer's Disease: Why Did Antioxidant Therapy Fail? , 2014, Oxidative medicine and cellular longevity.
[23] H. Jakubowski. Homocysteine in Protein Structure/Function and Human Disease , 2013, Springer Vienna.
[24] H. Yoo,et al. Congenital MTHFR deficiency causing early-onset cerebral stroke in a case homozygous for MTHFR thermolabile variant , 2013, Metabolic Brain Disease.
[25] J. Dorszewska,et al. Homocysteine and asymmetric dimethylarginine concentrations in the plasma of Alzheimer’s disease patients with varying degrees of dementia , 2013 .
[26] Charles D. Smith,et al. Induction of Hyperhomocysteinemia Models Vascular Dementia by Induction of Cerebral Microhemorrhages and Neuroinflammation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[27] J. Myers,et al. ENDURANCE EXERCISE TRAINING AND DIFERULOYL METHANE SUPPLEMENT: CHANGES IN NEUROTROPHIC FACTOR AND OXIDATIVE STRESS INDUCED BY LEAD IN RAT BRAIN , 2013, Biology of sport.
[28] M. Jabłoński,et al. Brain Ischemia Activates β- and γ-Secretase Cleavage of Amyloid Precursor Protein: Significance in Sporadic Alzheimer’s Disease , 2012, Molecular Neurobiology.
[29] Yun Chai,et al. Lipid peroxidation dysregulation in ischemic stroke: plasma 4-HNE as a potential biomarker? , 2012, Biochemical and biophysical research communications.
[30] M. Jabłoński,et al. Postischemic dementia with Alzheimer phenotype: selectively vulnerable versus resistant areas of the brain and neurodegeneration versus β-amyloid peptide. , 2012, Folia neuropathologica.
[31] M. Adamkov,et al. Intracellular Signaling MAPK Pathway After Cerebral Ischemia–Reperfusion Injury , 2012, Neurochemical Research.
[32] T. Yamashima,et al. Why are hippocampal CA1 neurons vulnerable but motor cortex neurons resistant to transient ischemia? , 2012, Journal of neurochemistry.
[33] S. Loureiro,et al. Homocysteine induces cytoskeletal remodeling and production of reactive oxygen species in cultured cortical astrocytes , 2010, Brain Research.
[34] M. Firbank,et al. Homocysteine is associated with hippocampal and white matter atrophy in older subjects with mild hypertension , 2010, International Psychogeriatrics.
[35] C. Matté,et al. Hyperhomocysteinemia reduces glutamate uptake in parietal cortex of rats , 2010, International Journal of Developmental Neuroscience.
[36] A. Buffo,et al. Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. , 2010, Biochemical pharmacology.
[37] Jia-min Zhuo,et al. Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease. , 2009, Current Alzheimer research.
[38] M. Jabłoński,et al. Alzheimer's Mechanisms in Ischemic Brain Degeneration , 2009, Anatomical record.
[39] Surojit Paul,et al. Homocysteine–NMDA receptor‐mediated activation of extracellular signal‐regulated kinase leads to neuronal cell death , 2009, Journal of neurochemistry.
[40] M. Mattson,et al. The organotellurium compound ammonium trichloro(dioxoethylene‐0,0′) tellurate enhances neuronal survival and improves functional outcome in an ischemic stroke model in mice , 2007, Journal of neurochemistry.
[41] W. Jagust,et al. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. , 2007, Brain : a journal of neurology.
[42] G. Weaving,et al. Behavioural and Psychological Symptoms of Alzheimer Type Dementia Are Not Correlated with Plasma Homocysteine Concentration , 2006, Dementia and Geriatric Cognitive Disorders.
[43] L. Gustafson,et al. Plasma Homocysteine, Cobalamin/Folate Status, and Vascular Disease in a Large Population of Psychogeriatric Patients , 2006, Dementia and Geriatric Cognitive Disorders.
[44] M. Pappolla,et al. Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels , 2006, Neurobiology of Disease.
[45] S. Lentz,et al. ADMA and hyperhomocysteinemia , 2005 .
[46] S. Lentz,et al. ADMA and hyperhomocysteinemia , 2005, Vascular medicine.
[47] A. Benedito‐Silva,et al. Physiological variation in plasma total homocysteine concentrations in rats. , 2005, Life sciences.
[48] M. Shoji,et al. Reduction of Cerebral Infarction in Stroke-Prone Spontaneously Hypertensive Rats by Statins Associated With Amelioration of Oxidative Stress , 2005, Stroke.
[49] R. Mayeux,et al. Stroke and the risk of Alzheimer disease. , 2003, Archives of neurology.
[50] S. Scheff,et al. Fluoro-jade B stains quiescent and reactive astrocytes in the rodent spinal cord. , 2003, Journal of neurotrauma.
[51] A. McCaddon,et al. Alzheimer’s disease and total plasma aminothiols , 2003, Biological Psychiatry.
[52] M. Wajner,et al. Reduction of Na+,K+-ATPase Activity in Hippocampus of Rats Subjected to Chemically Induced Hyperhomocysteinemia , 2002, Neurochemical Research.
[53] J. Colombo,et al. Fluoro Jade Stains Early and Reactive Astroglia in the Primate Cerebral Cortex , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[54] H. Wiśniewski,et al. Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer's β-amyloid protein precursor in the brain , 1994, Brain Research.
[55] K. Kogure,et al. Ischemia-induced slowly progressive neuronal damage in the rat brain , 1990, Neuroscience.
[56] Fred Plum,et al. Temporal profile of neuronal damage in a model of transient forebrain ischemia , 1982, Annals of neurology.
[57] M. Jabłoński,et al. Discrepancy in Expression of β-Secretase and Amyloid-β Protein Precursor in Alzheimer-Related Genes in the Rat Medial Temporal Lobe Cortex Following Transient Global Brain Ischemia. , 2016, Journal of Alzheimer's disease : JAD.
[58] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .